Subtotal hysterectomy reviewed: a stable or aperture for stump cervical malignancy. A referral hospital experience

Kamil Mosa Fram1, Shawqi Saleh1, Farah Fram1

  • 1The University of Jordan, Jordan.

Insights

Subtotal hysterectomy (STH) may lead to stump malignancy, presenting with abnormal bleeding or Pap smears. Stump cancer often shows a worse stage, necessitating careful consideration of surgical approach and patient counseling.

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology

Background:

  • Subtotal hysterectomy (STH) involves retaining the cervix, a practice with debated oncologic implications.
  • Malignancy arising from the cervical stump after STH is a recognized but less common complication.

Purpose of the Study:

  • To review the malignant potential of the cervical stump following subtotal abdominal hysterectomy.
  • To analyze the clinical presentation, primary site, and management of stump malignancies.

Main Methods:

  • Retrospective review of 33 patients diagnosed with stump malignancy between January 2018 and January 2022.
  • Patients had previously undergone subtotal hysterectomy (STH) at outside institutions.

Main Results:

  • Presenting symptoms included abnormal histopathology (24.24%), abnormal bleeding (21.21%), and postcoital bleeding/abnormal Pap smear (18.18%).
  • The most common primary sites were endometrial (51.51%) and cervical (15.15%).
  • Management involved surgery (54.54%), chemoradiation (27.27%), or palliative therapy (18.18%).

Conclusions:

  • Stump cancer cases tend to present at a more advanced stage compared to cancers in intact uteruses.
  • The potential for cervical stump problems warrants careful consideration before widespread adoption of STH.
  • Further prospective studies are needed to clarify the risks and benefits of retaining the cervix during hysterectomy.
Abstract

Related Concept Videos